Labshake search
Citations for Stemcell Technologies :
51 - 100 of 512 citations for Methyl 4 2 methoxynicotinoyl benzoate since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... and XAV939 (STEMCELL Technologies; 2 µM) were added in NM for 6 days ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% NeuroCult SM1 (Stemcell technologies, 05711), 2% HyClone™ Fetal Bovine Serum (Thermo Fisher Scientific ...
-
bioRxiv - Developmental Biology 2024Quote: ... 2 μM CHIR99021 (STEMCELL Technologies, 72054), 0.5 μM A83-01 ...
-
bioRxiv - Cell Biology 2024Quote: ... 2% PB plasma (STEMCELL Technologies, 70039), 10 µg/mL insulin (Sigma-Aldrich ...
-
bioRxiv - Cancer Biology 2024Quote: ... transferred into 4 mL methylcellulose (Stem Cell Technologies, 4434) and vortexed vigorously ...
-
bioRxiv - Neuroscience 2023Quote: ... 1.5 nM bone morphogenetic protein 4 (BMP4, Stemcell technologies) was added to the medium for another three days ...
-
bioRxiv - Immunology 2024Quote: ... TH2: 10 ng/mL IL-4 (StemCell Technologies #78047.1), 150 ng/µLIL-2 ...
-
bioRxiv - Cell Biology 2023Quote: ... with the addition of 1 μg/L of human interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Developmental Biology 2021Quote: ... Passaging occurred every 3-4 days using ReLeSR (STEMCELL Technologies) and DPBS 1X (Gibco ...
-
bioRxiv - Systems Biology 2020Quote: ... APC-CD49f (4 µL; Stem Cell Technologies 10109, clone VU1D9), Biotin-CD2 (8 µL ...
-
bioRxiv - Neuroscience 2020Quote: ... and banked into 3-4 vials using mFreSR (Stemcell Technologies). Clearance of Sendai virus was confirmed using qPCR (Supplementary Table 4) ...
-
bioRxiv - Neuroscience 2022Quote: ... Colonies were passaged every 4 days with ReLeSR (Stemcell technologies) after rinsing with Dulbecco’s phosphate-buffered saline (DPBS ...
-
bioRxiv - Cancer Biology 2021Quote: ... in a 3:4 mixture of media (StemCell Technologies # 05620) and Matrigel (BD Bioscience CB-40324) ...
-
bioRxiv - Cell Biology 2021Quote: IMR90-4 iPSCs (WiCell) were cultured in mTesR1 (Stemcell Technologies) on Matrigel (Corning ...
-
bioRxiv - Neuroscience 2022Quote: ... were passaged 1:4 using ACCUTASE™ (Stemcell technologies, 07920) when confluent and subsequently grown in Astrocyte medium containing leukemia inhibitory factor (LIF ...
-
bioRxiv - Neuroscience 2023Quote: ... and passaging every 4-5 days using ReLeSR (StemCell technologies). hES-qualified Matrigel (Corning ...
-
bioRxiv - Immunology 2023Quote: ... 4*106 iPSCs were seeded per Aggrewell 800 (Stemcell Technologies) in a 24-well plate in 2 ml embryonic body medium (EBM) ...
-
bioRxiv - Neuroscience 2024Quote: ... and passaged every 4 days using Accutase (StemCell Technologies, 07922) according to the manufacturer’s instructions ...
-
bioRxiv - Genomics 2020Quote: ... with 2 mM L-Glutamine (Stemcell Technologies), 1x 2-Mercaptoethanol (Millipore) ...
-
bioRxiv - Neuroscience 2021Quote: ... and 2 µM XAV939 (StemCell Technologies, 72674). TPM was changed every day from day 3 to day 7 ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with 2% SM1 (Stemcell Technologies; 05792), 5 mM L-Glutamine (Stemcell Technologies ...
-
bioRxiv - Genetics 2022Quote: ... supplemented with 2 µM Thiazovivin (StemCell Technologies) and plated in a Matrigel-coated 12-well plate at a density of 3 x 105 cells per well ...
-
bioRxiv - Cell Biology 2021Quote: ... supplemented with 2 mM EDTA (Stemcell Technologies) and pooled for antibody staining.
-
bioRxiv - Cell Biology 2022Quote: ... and 2% SM1 supplement (Stem Cell Technologies), and subsequently fed with astrocyte-conditioned BrainPhys media (Stem Cell Technologies ...
-
bioRxiv - Cell Biology 2022Quote: ... supplemented with 2% SM1 (StemCell Technologies #05711), 40 μg/mL gentamycin and 2.5 μg/mL Amphotericin B medium ...
-
bioRxiv - Pathology 2022Quote: ... supplemented with 2 µM Thiazovivin (StemCell Technologies) and plated in a Matrigel-coated 12-well plate at a density of 3 x 105 cells per well ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 2% SM1 (STEMCELL Technologies, 05792), 5 mM L-glutamine (STEMCELL Technologies ...
-
bioRxiv - Cancer Biology 2024Quote: ... 2 μg/ml heparin (Stemcell Technologies, 07980), and penicillin-streptomycin (Gibco ...
-
bioRxiv - Developmental Biology 2024Quote: ... in APEL 2 base medium (Stemcell Technologies). On day 3 ...
-
Single-cell profiling and zebrafish avatars reveal LGALS1 as immunomodulating target in glioblastomabioRxiv - Cancer Biology 2023Quote: ... heparin solution (2 mg/mL, STEMCELL Technologies), recombinant bFGF (20 ng/mL ...
-
bioRxiv - Molecular Biology 2022Quote: ... & 300 IU/mL IL-2 (STEMCELL Technologies). T cells were seeded at 2 × 106 cells/mL (typically 10×106 cells per well of a 6-well plate ...
-
bioRxiv - Cancer Biology 2023Quote: ... heparin (2 mg/mL, STEMCELL Technologies 07980), 1% penicillin/streptomycin ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 μg/ml mouse heparin (Stemcell technologies), 1X Pen/strept (Gibco) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 μg/ml mouse heparin (Stemcell technologies), 1X Pen/strept (Gibco) ...
-
bioRxiv - Cell Biology 2023Quote: ... and 2.5µM of IWP-2(Stemcell Technologies). Rudibaugh2 organoid media was supplemented with 100ng/mL SHH(VWR ...
-
bioRxiv - Neuroscience 2024Quote: ... and 2% NeuroCult SM1 Supplement (STEMCELL Tech.). For immunofluorescence ...
-
bioRxiv - Neuroscience 2024Quote: ... XAV939 (2 μM, Stemcell Technologies, Cat # 72672) and LDN-193189 (100 nM ...
-
bioRxiv - Neuroscience 2024Quote: ... XAV939 (2 μM, Stemcell Technologies, Cat # 72672) and LDN-193189 (100 nM ...
-
bioRxiv - Immunology 2024Quote: ... 150 ng/µLIL-2 (StemCell Technologies #78081), 5 ug/mL anti-IL-4 (clone 11B11 ...
-
bioRxiv - Developmental Biology 2024Quote: ... and 2 μM IWP2 (STEMCELL Technologies, 72124). The medium was refreshed daily for 4 days ...
-
bioRxiv - Cancer Biology 2024Quote: ... heparin (2 µg/ml; Stemcell Technologies, Inc.); 20 ng/mL human EGF and FGFb and 10 ng/mL platelet derived growth factors AA and BB (PeproTech ...
-
bioRxiv - Cancer Biology 2021Quote: ... in the same 3:4 mixture of media (StemCell Technologies #05620) and Matrigel (BD Bioscience CB-40324) ...
-
bioRxiv - Physiology 2020Quote: ... Cells were passaged routinely every 4 days using Dispase (STEMCELL Technologies). HIOs were generated according to protocols established in our lab (Múnera and Wells ...
-
bioRxiv - Neuroscience 2022Quote: ... and passaged every 3-4 days using ReLeSR (Stem Cell Technologies) until neural induction ...
-
bioRxiv - Neuroscience 2022Quote: ... and passaged every 3-4 days using ReLeSR (Stem Cell Technologies). Human iPSCs were edited for homozygous knockout of TAOK2 or heterozygous knock-in of the A135P mutation as described in Deneault et al.(Deneault et al. ...
-
bioRxiv - Microbiology 2023Quote: ... and 4 ug/mL Heparin sodium salt in PBS (StemCell Technologies) was replaced on the basolateral side only ...
-
bioRxiv - Cell Biology 2023Quote: ... Heparin 4 µg/mL (Ref 07980, Stemcell technologies, Saint Égrève, France) and Hydrocortisone 480 ng/mL (Ref 07925 ...
-
bioRxiv - Microbiology 2023Quote: ... and 4 ug/mL Heparin sodium salt in PBS (StemCell Technologies) was replaced on the basolateral side only ...
-
bioRxiv - Microbiology 2023Quote: ... and 4 µg/mL Heparin sodium salt in PBS (StemCell Technologies) was replaced on the basolateral side only ...
-
bioRxiv - Developmental Biology 2023Quote: ... Cells were split every 4 days using ReLeSR (STEMCELL Technologies Inc.) and plated 1×106 and 2×106 cells on Geltrex (Gibco ...